Decreased Blood Level of MFSD2a as a Potential Biomarker of Alzheimer’s Disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Decreased Blood Level of MFSD2a as a Potential Biomarker of Alzheimer’s Disease
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 1, Pages 70
Publisher
MDPI AG
Online
2019-12-20
DOI
10.3390/ijms21010070
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma and Brain Fatty Acid Profiles in Mild Cognitive Impairment and Alzheimer's Disease
- (2018) Stephen C. Cunnane et al. JOURNAL OF ALZHEIMERS DISEASE
- Homozygous mutation in MFSD2A, encoding a lysolipid transporter for docosahexanoic acid, is associated with microcephaly and hypomyelination
- (2018) Tamar Harel et al. NEUROGENETICS
- Short-Term Fish Oil Treatment Changes the Composition of Phospholipids While Not Affecting the Expression of Mfsd2a Omega-3 Transporter in the Brain and Liver of the 5xFAD Mouse Model of Alzheimer’s Disease
- (2018) Desanka Milanovic et al. Nutrients
- The lysolipid transporter Mfsd2a regulates lipogenesis in the developing brain
- (2018) Jia Pei Chan et al. PLOS BIOLOGY
- Insights into major facilitator superfamily domain-containing protein-2a (Mfsd2a) in physiology and pathophysiology. What do we know so far?
- (2018) Pinar Eser Ocak et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Fatty acid transporting proteins: Roles in brain development, aging, and stroke
- (2017) Wenting Zhang et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Mfsd2a Is a Transporter for the Essential ω-3 Fatty Acid Docosahexaenoic Acid (DHA) in Eye and Is Important for Photoreceptor Cell Development
- (2016) Bernice H. Wong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Insights into the Transport Mechanism of the Human Sodium-dependent Lysophosphatidylcholine Transporter MFSD2A
- (2016) Debra Q. Y. Quek et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The importance of n-6/n-3 fatty acids ratio in the major depressive disorder
- (2016) Kristian Søborg Husted et al. Medicina-Lithuania
- Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease
- (2016) Jessay Gopuran Devassy et al. Advances in Nutrition
- High‐Fat‐Diet Intake Enhances Cerebral Amyloid Angiopathy and Cognitive Impairment in a Mouse Model of Alzheimer's Disease, Independently of Metabolic Disorders
- (2016) Bowen Lin et al. Journal of the American Heart Association
- The importance of n-6/n-3 fatty acids ratio in the major depressive disorder
- (2016) Kristian Søborg Husted et al. Medicina-Lithuania
- Socio-economic Aspects of Alzheimer's Disease
- (2015) Petra Maresova et al. Current Alzheimer Research
- Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis
- (2015) Mingqin Zhu et al. MOLECULAR NEUROBIOLOGY
- A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome
- (2015) Vafa Alakbarzade et al. NATURE GENETICS
- Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome
- (2015) Alicia Guemez-Gamboa et al. NATURE GENETICS
- Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
- (2014) Christopher D. Buckley et al. IMMUNITY
- Mfsd2a is critical for the formation and function of the blood–brain barrier
- (2014) Ayal Ben-Zvi et al. NATURE
- Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid
- (2014) Long N. Nguyen et al. NATURE
- 2013 Alzheimer's disease facts and figures
- (2013) Alzheimers & Dementia
- Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis
- (2013) Sofia Lopes da Silva et al. Alzheimers & Dementia
- Resolvin D1, an Endogenous Lipid Mediator for Inactivation of Inflammation-Related Signaling Pathways in Microglial Cells, Prevents Lipopolysaccharide-Induced Inflammatory Responses
- (2013) Min-Xuan Xu et al. CNS Neuroscience & Therapeutics
- Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study
- (2013) Y. Freund Levi et al. JOURNAL OF INTERNAL MEDICINE
- Major Facilitator Superfamily Domain-Containing Protein 2a (MFSD2A) Has Roles in Body Growth, Motor Function, and Lipid Metabolism
- (2012) Justin H. Berger et al. PLoS One
- Docosahexaenoic Acid Signalolipidomics in Nutrition: Significance in Aging, Neuroinflammation, Macular Degeneration, Alzheimer's, and Other Neurodegenerative Diseases
- (2011) Nicolas G. Bazan et al. Annual Review of Nutrition
- Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease
- (2010) De-Cai Wang et al. NEUROBIOLOGY OF AGING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now